1. WHO. Classification of Tumours Editorial Board WHO classification of tumours, 5th ed Female genital tumours. Lyon: International Agency for Research on Cancer;2020.
2. Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007; 31:664–72.
Article
3. Kawakami F, Mikami Y, Kojima A, Ito M, Nishimura R, Manabe T. Diagnostic reproducibility in gastric-type mucinous adenocarcinoma of the uterine cervix: validation of novel diagnostic criteria. Histopathology. 2010; 56:551–3.
Article
4. Kondo T, Hashi A, Murata SI, et al. Gastric mucin is expressed in a subset of endocervical tunnel clusters: type A tunnel clusters of gastric phenotype. Histopathology. 2007; 50:843–50.
Article
5. Hodgson A, Parra-Herran C, Mirkovic J. Immunohistochemical expression of HIK1083 and MUC6 in endometrial carcinomas. Histopathology. 2019; 75:552–8.
Article
6. Castanon A, Landy R, Sasieni PD. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? Int J Cancer. 2016; 139:1040–5.
Article
7. Wilbur DC, Chhieng DC, Guidos B, Mody DR. Epithelial abnormalities: glandular. Nayar R, Wilbur DC, editors. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. 3rd ed. Heidelberg: Springer;2015. p. 193–240.
Article
8. Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019; 145:129–35.
Article
9. Stolnicu S, Barsan I, Hoang L, et al. International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol. 2018; 42:214–26.
10. Talia KL, Oliva E, Rabban JT, Singh N, Stolnicu S, McCluggage WG. Grading of endocervical adenocarcinomas: review of the literature and recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021; 40(Suppl 1):S66–74.
Article
11. Lu S, Shen D, Zhao Y, Kang N, Wang X. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases. Diagn Pathol. 2019; 14:72.
Article
12. Kawakami F, Mikami Y, Sudo T, Fujiwara K, Hirose T, Itoh T. Cytologic features of gastric-type adenocarcinoma of the uterine cervix. Diagn Cytopathol. 2015; 43:791–6.
Article
13. Schwock J, Starova B, Khan ZF, et al. Cytomorphologic features of gastric-type endocervical adenocarcinoma in liquid-based preparations. Acta Cytol. 2021; 65:56–66.
Article
14. Hissong E, Yoxtheimer LM, Pacecca A, Hoda RS. Cytology of minimal deviation endocervical adenocarcinoma (adenoma malignum) on a ThinPrep Pap test. Diagn Cytopathol. 2016; 44:552–5.
Article
15. Ryu A, Nagata S, Kubo C, et al. Conventional direct smear yields diagnostic indicators of gastric-type mucinous carcinoma compared with cytomorphological features identified by liquid-based cervical cytology. Acta Cytol. 2021; 65:150–7.
Article
16. Hata S, Mikami Y, Manabe T. Diagnostic significance of endocervical glandular cells with “golden-yellow” mucin on pap smear. Diagn Cytopathol. 2002; 27:80–4.
Article
17. Omori M, Kondo T, Nakazawa K, et al. Interpretation of endocervical cells with gastric-type mucin on Pap smears. Am J Clin Pathol. 2018; 150:259–66.
Article
18. Hashi A, Yuminamochi T, Xu JY, Kondo T, Katoh R, Hoshi K. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix. Diagn Cytopathol. 2008; 36:535–44.
Article
19. Lee Y, Lee C, Park IA, An HJ, Kim H. Cytomorphological features of hyperchromatic crowded groups in liquid-based cervicovaginal cytology: a single institutional experience. J Pathol Transl Med. 2019; 53:393–8.
Article